AFNET – the Atrial Fibrillation NETwork

Physicians and scientists co-operate within the AFNET. A network is formed by hospitals and doctors’ offices – reaching from GPs to university hospitals.

Atrial Fibrillation – Information for Patients

Atrial Fibrillation is the most common arrhythmia of the heart – especially in elderly people. We inform you about the current treatment options.

Research – Clinical Trials on a European Level

Several million people in Europe live with atrial fibrillation. We investigate new treatment options. Within AFNET trials scientists co-operate on a European level.

Results – for a better treatment

New findings from AFNET trials flow into the clinical routine. AFNET experts develop recommendations for the therapy of atrial fibrillation.




[20.03.2018 ] Press release of the European Society of Cardiology (ESC)... [read more]
[01.08.2017 ] AFNET is happy to announce to have joined Twitter! From... [read more]
[30.08.2016 ] On August 27th 2016 the ESC isued a press release on new AF... [read more]
[22.06.2016 ] Atrial fibrillation (AF) is a common cause of stroke, and... [read more]
[10.06.2016 ] AFNET scientists were significantly involved. The consensus... [read more]
[30.05.2016 ] The pan-European clinical trial “Early treatment of atrial... [read more]
[18.01.2016 ] Using catheter ablation to create complete linear lesions... [read more]
[19.10.2015 ] At least 30 million people worldwide live with atrial... [read more]
[19.06.2015 ] Today the 2000th patient has been enrolled in the EAST –... [read more]